市場調査レポート
商品コード
1360400
網膜硝子体手術機器の世界市場の規模、シェア、成長分析:製品別、エンドユーザー別 - 産業予測(2023年~2030年)Global Vitreoretinal Surgery Devices Market Size, Share, Growth Analysis, By Product(Solar Photocoagulation Lasers, Illumination Devices), By End user(Hospitals, Specialty Clinics) - Industry Forecast 2023-2030 |
網膜硝子体手術機器の世界市場の規模、シェア、成長分析:製品別、エンドユーザー別 - 産業予測(2023年~2030年) |
出版日: 2023年09月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
世界の網膜硝子体手術機器の市場規模は、2022年の21億9,000万米ドルから2030年までに34億5,000万米ドルに達し、予測期間(2023年~2030年)にCAGRで5.84%の成長が予測されています。
眼疾患の罹患率の上昇と医療技術の進歩により、市場は成長を示しています。主要企業は、硝子体手術機器、手術用レーザー、照明器具などの革新的な機器に注力しています。北米と欧州は医療インフラが整っているため、市場を独占しています。認知度の向上と高齢化がこれらの機器の需要に寄与しており、市場は今後も拡大が続くと予想されます。
世界の老年人口の増加は、黄斑変性症や糖尿病網膜症のような加齢に関連する眼疾患の症例急増の重大な要因であり、網膜硝子体手術の急増につながっています。この人口動態の変化は、老年人口の視覚の健康維持における網膜硝子体手術機器の重要性が増していることから、網膜硝子体手術機器への要求を後押ししています。
網膜硝子体手術機器の使用や関連手術には、機械、消耗品、熟練した医療スタッフなど、多額の費用がかかります。このような高額な出費は、特に医療予算が限られている地域では、これらの治療へのアクセスを制限する可能性があり、市場の成長可能性を阻害します。
市場の現状を特徴付けているのは、技術の進歩です。ロボット支援手術、精巧な視覚化プラットフォーム、侵襲性の低い手術アプローチなどの先進技術の統合により、精度、生産性、患者の結果が向上しています。このような技術革新の波は、医療関係者や患者にとっても魅力的であり、安全性と有効性の高さで知られる精巧な機器の受け入れを促しています。
当レポートでは、世界の網膜硝子体手術機器市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
Global Vitreoretinal Surgery Devices Market size was valued at USD 2.07 billion in 2021 and is poised to grow from USD 2.19 billion in 2022 to USD 3.45 billion by 2030, growing at a CAGR of 5.84% in the forecast period (2023-2030).
The Global Vitreoretinal Surgery Devices Market encompasses surgical instruments and equipment used for treating disorders of the vitreous and retina. With a rising incidence of eye diseases and advancements in medical technology, the market is experiencing growth. Key players focus on innovative devices, such as vitrectomy machines, surgical lasers, and illumination tools. North America and Europe dominate the market due to healthcare infrastructure. The market is expected to continue its expansion with increasing awareness and aging populations contributing to the demand for these devices.
Top-down and bottom-up approaches were used to estimate and validate the size of vitreoretinal surgery devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The global vitreoretinal surgery devices market is segmented on the basis of Product, End user and region. By Product, the market is segmented into Solar Photocoagulation Lasers, Vitreoretinal Packs, Illumination Devices, Vitrectomy Machines, Vitrectomy Probes, Others. By End user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The escalation of the worldwide elderly populace is a significant factor behind the surge in cases of age-related ocular ailments like macular degeneration and diabetic retinopathy, leading to an uptick in vitreoretinal surgeries. This demographic shift is propelling the requirement for vitreoretinal surgery devices, given their increasing importance in preserving visual well-being among the senior population.
The employment of vitreoretinal surgery devices and the relevant procedures can incur substantial expenses, covering machinery, disposables, and proficient healthcare staff. Such elevated expenditures might constrain the accessibility of these treatments, notably in areas with restricted medical budgets, thereby hindering the growth potential of the market.
Technological progress and inventive strides characterize the current state of the vitreoretinal surgery devices market. The integration of advanced technologies like robotic-assisted procedures, sophisticated visualization platforms, and less invasive surgical approaches is elevating the accuracy, productivity, and patient results. This wave of innovations appeals to medical professionals and patients alike, stimulating the acceptance of sophisticated devices renowned for their heightened safety and effectiveness.